Search Results

Site Search

Diagnosis and inflammation monitoring - Insights

Patients with symptoms that arouse clinical suspicion of either inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) are both common and tough to differentiate.

Exploratory testing - Insights

Mayo Clinic Laboratories’ whole exome and whole genome sequencing assays provide in-depth interrogation of all the genes in the human genome, offering individualized insights for optimal outcomes.

Cardiovascular Pathology Services at Mayo Clinic Laboratories

Cardiovascular pathology focuses on a multidisciplinary approach to the consultative practice. Learn more about our service.

Prenatal - Insights

Including carrier screening, molecular testing, and cytogenetic analysis, Mayo Clinic Laboratories prenatal evaluations provide vital insights for prospective and expecting parents.

Thiopurine Management Testing for IBD - Mayo Clinic Laboratories

Thiopurine management is important because it can detect individuals with low thiopurinemethyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.

Genetic liver disease - Insights

Identifying underlying genetic disorders plays an important role in the treatment and care of patients with liver disease. Appropriate use of screening tests in routine clinical practice can rule out possible causes of liver disease and...

Thiopurines - Insights

For children who require thiopurine medications (such as azathioprine and 6-mercaptopurine) to treat inflammatory bowel disease (IBD), understanding how thiopurines are metabolized is vital to choosing the most effective treatment. Because...

Chain of custody drug testing - Insights

Chain of custody testing at Mayo Clinic Laboratories is performed on urine, serum, and meconium and adheres to the highest quality standards to provide secure results.

Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D. - Insights

Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune...

CPT codes and LOINC update: January 2023 - Insights

This page includes updates posted to the site during the month of January.

Benign Hematology Testing - Mayo Clinic Laboratories

Our metabolic hematology laboratory is dedicated to providing accurate diagnoses and interpretations with an emphasis on clinical significance for your patients.

Acute Myeloid Leukemia Testing - Mayo Clinic Laboratories

Find out how our clinically validated testing for acute myeloid leukemia can provide critical diagnostic, prognostic, and therapeutic information for physicians.

Stories - Insights

Beyond the test result Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’

Autoimmune profile updates - Insights

Based on studies that have shown certain antibodies may not be as clinically relevant to autoimmune testing as previously thought, Mayo Clinic Laboratories is updating a number of its autoimmune profiles by removing some antibodies from...

Appropriate Use of Gastrointestinal Pathogen Panel by PCR [Utilization Spotlight] - Insights

Infectious diarrhea is a common and usually self-limited illness. While most patients with infectious causes of diarrhea will get better on their own, there are certain scenarios in which testing is indicated. The The FilmArray...

Testing Archives - Page 20 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 17 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

5 Tips for Effectively Surveying Lab Customers - Insights

Surveys are crucial for strengthening laboratory operations. Get insights for how to make them as effective as possible.

Patient information - Insights

Learn more about how Mayo Clinic Laboratories’ lupus testing can helping patients understand their disease activity and flare risk.

Managing off-site phlebotomy: Considerations, coordination, and convenience - Insights

As the phlebotomist ventures farther from the hospital or formal outpatient setting, there are many new facets to consider. Remote phlebotomy is a patient-focused activity and can be a successful attribute for an outreach program when...

Whole genome sequencing streamlines diagnosis - Insights

Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC, explain how Mayo Clinic Laboratories' whole genome sequencing provides comprehensive information for rapid diagnosis of hereditary disorders.

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D. - Insights

Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma/Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and...

Neurofilament Light Chain (NFLC) - Insights

Alicia Algeciras, Ph.D., describes Mayo Clinic Laboratories’ new blood test to detect NFLC, or neurofilament light chain protein. NFLC is a biomarker for several neurodegenerative conditions. The new assay can determine if a patient’s...

Results report simplifies urine test interpretation: John Lieske, M.D. - Insights

John Lieske, M.D., explains why it's now easier for clinicians to pull information from Mayo Clinic Laboratories' supersaturation test report. An updated format summarizes complex information to help guide the treatment of kidney stones.

Site Map

Site Map Test Catalog Test Information Test Updates New Tests CPT Code & Test Classification Updates DEX Z-Code...

MCL Chimerism Analysis Information MC1235124

MCL Chimerism Analysis Information Complete print Reset Form Chimerism Analysis Information separate form specimen submitted Note results

congenital-disorders-of-glycosylation-algorithm.pdf

Unexplained developmental delay, multisystemic disease with or without a neurologic component, multiple unexplained abnormalities of basic laboratory resultsa ■ CDGN - consistent with type I CDG (congenital disorder of glycosylation)...

Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 12 - Insights

This week’s Research Roundup highlights a mechanism for preventing asymmetric histone segregation onto replicating DNA strands.

Platelet testing - Insights

Learn how reliable laboratory diagnosis of a platelet disorders can impact patients’ and their family members' clinical management and outcomes.

Talking omicron with Matthew Binnicker, Ph.D. - Insights

With the omicron variant grabbing headlines around the world, media outlets have turned to experts like Dr. Binnicker to help clarify the effect this new variant could have and what it might mean for the COVID-19 pandemic.

The Past, Present, and Future of Laboratory Automation - Insights

PACE / State of FL - This “Continual Improvement” webinar provides an overview of automating laboratory workflows and its impact on the overall efficiency of testing by speeding up tasks, minimizing waste, reducing reagent usage, and...

People Archives - Page 37 of 37 - Insights

Skip to Content MayoACCESS MayoLINK...

Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., Weigh in on Opioids in Clinical Laboratory News - Insights

Opioids remain a mainstay of pain management, upping the stakes for monitoring prescription compliance and detecting abuse. Paul Jannetto, Ph.D., Director of the Clinical and Forensic Toxicology Laboratory at Mayo Clinic, and Loralie...

What's New in Quality and Regulatory Expectations for Laboratories? [2022] - Insights

PACE / State of FLThis “Continual Improvement” webinar will provide an overview of new or changed regulations for 2022, and other regulatory issues that have the potential to affect clinical laboratories. The latter half of the year has...

CPT Codes and LOINC Updates Archives - Insights

Skip to Content MayoACCESS MayoLINK...

Anti-Platelet Factor 4 Antibody-Mediated Prothrombotic Syndromes - Insights

PACE / State of FLIn this month's "Virtual Lecture," Anand Padmanabhan provides a general overview and science in the field related to heparin-induced thrombocytopenia (HIT), vaccine-induced thrombotic thrombocytopenia (VITT), and...

Keys to Leading in Extraordinarily Difficult Times: Part 1 - Insights

PACE / State of FLIn this month’s “Virtual Lecture” Mark Hyde shares what he has learned during his 28 years of workplace consulting experience and counseling with thousands of employees concerning work topics such as stress, fatigue,...

Mayo Clinic Laboratory and Pathology Research Roundup: April 16 - Insights

This week's research roundup feature: R0 resection and radiation therapy have been associated with improved overall survival (OS) in patients with thymic carcinoma (TC). Here, we analyzed which subgroups of patients derive the greatest...

Mayo Clinic Laboratory and Pathology Research Roundup: March 26 - Insights

This week's research roundup feature: Implant-associated infections (IAIs) pose serious threats to patients and can be associated with significant morbidity and mortality. These infections may be difficult to diagnose due, in part, to...

Industry Archives - Page 6 of 6 - Insights

Skip to Content MayoACCESS MayoLINK...

Perspectives Archives - Page 9 of 9 - Insights

Skip to Content MayoACCESS MayoLINK...

Diversity and Inclusion Meets Quality and Safety: It's Not Quality Unless It's Quality for All - Insights

In this sketchnote, John Knudsen, M.D., discusses the impact of systemic discrimination, bias, and racism on the quality and safety of health care. He calls for data to drive action on inequities and measure the success of interventions.

Culturally Sensitive and Medically Appropriate Care for Transgender Patients Sketchnote - Insights

In this sketchnote, Caroline Davidge-Pitts, M.B., B.Ch., and Todd Nippoldt, M.D., share inclusive terminology and lessons learned from Mayo Clinic’s Transgender Intersex Specialty Care Clinic.

Classification of Kidney Stone Composition Using an AI Model - Insights

PACE / State of FLThis month’s “Virtual Lecture,” discusses how artificial intelligence can be utilized to classify kidney stones while demonstrating improvement in quality and patient safety.

Complement Testing in the Diagnosis and Management of Thrombotic Microangiopathy - Insights

PACE / State of FLThis month’s “Virtual Lecture” discusses the clinical diagnosis and management, summarizes the testing modalities that guide diagnosis and management, and recognizes the utility of genetic testing as it relates to...

Mayo Clinic Laboratory and Pathology Research Roundup: July 9 - Insights

This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.

Mayo Clinic Laboratory and Pathology Research Roundup: May 14 - Insights

This week's research roundup feature: Despite advances in understanding the genetic abnormalities in myeloproliferative neoplasms (MPNs) and the development of JAK2 inhibitors, there is an urgent need to devise new treatment strategies,...